Symbol | Exchange | Currency |
|---|
Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases,...
Investing.com - Terns Pharmaceuticals (NASDAQ: TERN) reported first quarter EPS of $-0.31, $0.02 worse than the analyst estimate of $-0.29. Revenue for the quarter came in at...
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, non-alcoholic steatohepatitis (NASH) and obesity. Its product pipeline includes TERN-701, TERN-501, TERN-601 and TERN-101. ItsTERN-701 is an oral, potent, allosteric BCR-ABL tyrosine kinase inhibitor (TKI) specifically targeting the ABL myristoyl pocket for chronic myeloid leukemia. The TERN-501 is its highly selective thyroid hormone receptor beta (THR-b) agonist for non-alcoholic steatohepatitis (NASH) in Phase IIa clinical development. TERN-601 is a small-molecule glucagon-like peptide-1 receptor (GLP-1R) agonist for metabolic diseases such as obesity. TERN-101 is a liver-distributed, non-bile acid Farnesoid X Receptor (FXR), agonist that has demonstrated a differentiated tolerability profile and improved target engagement due to its sustained FXR activation in the liver.
| Average | 16.00 (+47.47% Upside) |
| High | 19.00 |
| Low | 11.00 |
| Price | 10.85 |
| No. of Analysts | 5 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Sell | Buy |
| Technical Indicators | Strong Sell | Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 88.29 | 89.24 | 88.10 | +0.15 | +0.17% | 12.81M | NYSE | |||
| 30.03 | 30.07 | 29.43 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 59.00 | 60.40 | 58.97 | -0.30 | -0.51% | 10.09M | NYSE | |||
| 0.41 | 0.423 | 0.38 | +0.028 | +7.21% | 200.12K | NASDAQ | |||
| 71.42 | 71.50 | 66.72 | +11.40 | +18.99% | 26.33M | NASDAQ | |||
| 1.09 | 1.14 | 1.04 | +0.07 | +6.86% | 179.82K | NYSE | |||
| 125.43 | 126.00 | 123.29 | +1.08 | +0.87% | 25.17M | NASDAQ | |||
| 23.90 | 24.10 | 23.50 | +0.29 | +1.23% | 1.73M | NYSE | |||
| 7.70 | 7.84 | 7.54 | +0.16 | +2.12% | 43.11M | NYSE | |||
| 0.062 | 0.07 | 0.04 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 2.18 | 2.39 | 2.101 | -0.100 | -4.39% | 35.81K | NASDAQ | |||
| 1.10 | 1.15 | 1.05 | -0.04 | -3.51% | 1.90M | NASDAQ | |||
| 27.56 | 27.74 | 25.87 | +1.67 | +6.45% | 7.19M | NYSE | |||
| 1.01 | 1.02 | 1.01 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 60.10 | 61.72 | 58.88 | +1.02 | +1.73% | 3.91M | NYSE |